INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined strawberries. Clear

6 studies

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2017 / Randomized crossover trial

Adding freeze-dried strawberry powder to a high-fat meal did not alter postprandial vascular markers.

A randomized crossover trial in 30 overweight or obese adults assessed the impact of adding 40 g of freeze-dried strawberry powder to a high-fat meal. No significant differences appeared between the strawberry and control meals for any vascular or metabolic outcome. Both meals similarly reduced the augmentation index at 2 and 4 hours (P < 0.002) and increased postprandial triglycerides, insulin, and glucose relative to baseline (P < 0.001).

Richter CK, Skulas-Ray AC, Gaugler TL, et al. Am J Clin Nutr, 2017. PMID 28003205

2017 / Randomized crossover trial

A mixed berry drink lowered cholesterol and improved working memory in older adults

Forty healthy older adults aged 50 to 70 consumed a mixed berry beverage or a matched control beverage daily for five weeks in a randomized crossover trial. The berry drink reduced total and LDL cholesterol compared to baseline (P < 0.05) and compared to control (P < 0.005 and P < 0.01). Working memory performance improved after the berry beverage compared to control (P < 0.05), but other cardiometabolic variables remained unchanged.

Nilsson A, Salo I, Plaza M, et al. PLoS One, 2017. PMID 29141041

2014 / Intervention study (pre-post with washout)

Consuming 500 g of strawberries daily for 1 month improved lipid profiles, antioxidant markers, and platelet function in healthy volunteers.

Healthy volunteers consumed 500 g of strawberries daily for 1 month, with evaluations at baseline, day 30, and after a 15-day washout. Strawberry intake significantly reduced total cholesterol (-8.78%), LDL cholesterol (-13.72%), and triglycerides (-20.80%), while HDL cholesterol was unchanged. It also reduced serum malondialdehyde (-31.40%), urinary 8-OHdG (-29.67%), isoprostanes (-27.90%), and spontaneous and oxidative hemolysis (-31.7% and -39.03%, all P<.05). Total antioxidant capacity, vitamin C, and reductions in activated platelets were also significantly improved.

Alvarez-Suarez JM, Giampieri F, Tulipani S, et al. J Nutr Biochem, 2014. PMID 24406274

2010 / Randomized, single-blind, placebo-controlled crossover trial

A strawberry beverage modulated postprandial lipemia and LDL oxidation after a high-fat meal.

In a randomized crossover study involving 24 hyperlipidemic adults, participants consumed either a strawberry drink or an energy-matched placebo for 6 weeks. Following a high-fat challenge meal during the run-in period, postprandial triglycerides and oxidized LDL were lower after the strawberry drink than placebo. High-fat meal testing after 6 weeks showed decreased lipid levels and an interaction between sex and treatment for oxidized LDL (p < 0.0001 and p = 0.0002).

Burton-Freeman B, Linares A, Hyson D, et al. J Am Coll Nutr, 2010. PMID 20595645

2011 / Prospective cohort study

Higher anthocyanin intake, predominantly from blueberries and strawberries, was linked to a lower risk of incident hypertension.

Researchers evaluated the relationship between habitual flavonoid intake and incident hypertension among 87,242 women from NHS II, 46,672 women from NHS I, and 23,043 men from HPFS over 14 years of follow-up. During follow-up, 29,018 hypertension cases in women and 5,629 in men were reported. In pooled multivariate-adjusted analyses, participants in the highest quintile of anthocyanin intake had an 8% lower risk of hypertension (RR: 0.92; 95% CI: 0.86, 0.98; P < 0.03) compared with the lowest quintile, with a 12% lower risk in participants aged ≤60 years (RR: 0.88; 95% CI: 0.84, 0.93; P < 0.001). Highest intake of apigenin was linked to a 5% risk reduction (95% CI: 0.91, 0.99; P = 0.005), and catechin intake was linked to a 6% lower risk (95% CI: 0.88, 0.97; P = 0.002) in those aged ≤60 years.

Shows an association, not proof of cause and effect.

Cassidy A, O'Reilly ÉJ, Kay C, et al. Am J Clin Nutr, 2011. PMID 21106916